ClinicalTrials.gg
Drug

Ursodeoxycholic Acid clinical trials

Also written Ursodiol and Urso.

studies test it
97
open now
18
in phase 3
23
first study started
1994

How each study uses Ursodeoxycholic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ursodeoxycholic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Dec 1987 · ACTIGALL · NDA 019594 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ursodeoxycholic Acid
52
ursodeoxycholic acid (UDCA)
5
Ursofalk
4
UDCA (Ursodeoxycholic acid)
4
Ursodeoxycholic acid (UDCA) 500 mg
3

Brand

Urso
4
Ursonorm
1
URSO 250
1

Other names

Ursodiol
20
UDCA
18
Ursodiol 500 MG
3
Actigall
2
Ursodesoxycholic acid
1

Studies by the year they started

97 studies that test it; most in 2026 (9)

Studies that test Ursodeoxycholic Acid, by start year
YearStudies
19941
19951
19981
20011
20023
20031
20042
20052
20062
20073
20084
20094
20104
20111
20121
20133
20145
20153
20166
20174
20184
20193
20204
20218
20223
20237
20246
20251
20269

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
17
Phase 2
28
Phase 3
23
Phase 4
21
No phase
18

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 83

Daewoong Pharmaceutical Co. LTD. (7) · Tanta University (4) · Institute of Liver and Biliary Sciences, India (2) · Teva Pharmaceuticals USA (2) · Radboud University Medical Center (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Dr. Falk Pharma GmbH (2) · Jinling Hospital, China (2)

Often tested with

Tested in the same studies.

Pentoxifylline (3) · Thiamine (2) · Sitagliptin (2) · Fenofibrate (2) · Omega-3 fatty acid (1) · Phototherapy (1) · Zinc Sulfate (1) · Nirmatrelvir and ritonavir drug combination (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Ursodeoxycholic Acid is the comparator. A study of two new drugs counts under both.

  • 1Fenofibrate · Xijing Hospital of Digestive Diseases · next primary completion Dec 2028
Reaching primary completion within a year · 8, 3 in phase 3

Studies that test Ursodeoxycholic Acid, phase 3 first.

Studies

Open first, then newest update. How each study uses Ursodeoxycholic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 97

See all 97 studies that test Ursodeoxycholic Acid →

Given beside what is tested · 24 — Ursodeoxycholic Acid is usual care or a partner of the new treatment

Showing 20 of 24.

As the comparator · 14 — what is tested is compared with Ursodeoxycholic Acid

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Ursodeoxycholic Acid · ClinicalTrials.gg INT008389

  • MeSH (NLM) D014580Ursodeoxycholic AcidConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 724L30Y2QRURSODIOLConfirmed FDA, NLM
  • RxNorm 11065One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.